MLKL and Hepatitis: In consistent with Zbp1 siRNA-GeRP treatment group, Mlkl siRNA-GeRP injection also alleviated BDL-induced liver inflammation (Fig. 10C), injury (Fig. 10D) and fibrosis (Fig. 10E–G).